Tweetovi

Blokirali ste korisnika/cu @PharmaNetwrking

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @PharmaNetwrking

  1. Poništi
  2. proslijedio/la je Tweet
    Poništi
  3. PN Update: Bonfiglioli Engineering Inspection Post Issue 1

    Poništi
  4. 4. velj

    PN Update: Pathology, Blood and Transplant Sciences

    Poništi
  5. 4. velj
    Poništi
  6. proslijedio/la je Tweet

    Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA

    Poništi
  7. proslijedio/la je Tweet

    Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs

    Poništi
  8. proslijedio/la je Tweet
    3. velj

    Using to analyse developing lung cells in vitro revealed what promotes them to develop and allowed to create better quality lung tissue models. Read story here:

    Poništi
  9. 4. velj

    PN Update: Sofrigam’s entity Coldway showing a disruptive refrigeration technology for urban deliveries at MOVE 2020

    Poništi
  10. 4. velj

    PN Update: Zenatek bringing ZTS temperature-sensitive control to FRUIT LOGISTICA Berlin

    Poništi
  11. proslijedio/la je Tweet
    31. sij

    “And we’ll take a cup of kindness yet, for auld lang syne”. This traditional song mostly sung at year’s end to say a goodbye. We rather say “see you later”: UK has been part of PHOENIX group for more than 22 years – and it will stay that way. Let’s keep drinking cups of kindness!

    Poništi
  12. 3. velj

    PN Update: Progress-EXS to highlight Lean Six Sigma service at Innovations for Health 2020

    Poništi
  13. 31. sij

    PN Update: Book a meeting with Pharmatrans at IPEC annual forum to know more about new DICOM SANAQ Co-Processed platform

    Poništi
  14. 31. sij

    PN Update: Dec Group featuring SafeDock high containment solution at Solids Zurich

    Poništi
  15. proslijedio/la je Tweet
    30. sij

    A study from and has shown that targeting mtp53 and PARP in triple negative breast cancer could inhibit tumour growth and provide a new treatment option. Click here to find out more:

    Poništi
  16. proslijedio/la je Tweet
    30. sij

    Our RNAiONE™ technology provides customized gene silencing for target validation and drug discovery. Learn more about our unique technology:

    Poništi
  17. proslijedio/la je Tweet
    30. sij

    We are excited to join the "Tabletting School" . Workshops will be performed on 2 STYL'One Nano & we will inform about tablet compaction data analysis, formulation development using principles and DOI.

    Poništi
  18. 31. sij

    PN Update: SIRION Biotech aims for IPO public share offering

    Poništi
  19. 30. sij

    PN Update: Continued Process Verification

    Poništi
  20. 30. sij

    PN Update: Bachem brings advanced insights to Iberian Peptide Meeting Madrid

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·